ClinicalTrials.gg
Drug

Ipragliflozin clinical trials

Also written ASP1941.

studies test it
48
open now
0
in phase 3
16
first study started
2006

How each study uses ipragliflozin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

ipragliflozin
31
Suglat
7

Development codes

ASP1941
44

Studies by the year they started

48 studies that test it; most in 2010 (15)

Studies that test ipragliflozin, by start year
YearStudies
20062
20072
20083
20094
201015
20118
20122
20131
20142
20154
20163
20172

By phase

A phase 1/2 study counts in both.

Phase 1
22
Phase 2
5
Phase 3
16
Phase 4
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 46 · Other 2

Astellas Pharma Inc (38) · Astellas Pharma Europe B.V. (3) · Astellas Pharma Korea, Inc. (2) · Merck Sharp & Dohme LLC (2) · Seoul National University Bundang Hospital (1) · Yonsei University (1) · Astellas Pharma Global Development, Inc. (1)

Often tested with

Tested in the same studies.

Glimepiride (2) · Nateglinide (1) · DPP-4 inhibitors (1) · Insulin (1) · Furosemide (1) · Mitiglinide (1) · Miglitol (1) · Sitagliptin (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses ipragliflozin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 48

See all 48 studies that test ipragliflozin →

Given beside what is tested · 1 — ipragliflozin is usual care or a partner of the new treatment

Codes

What other systems call ipragliflozin · ClinicalTrials.gg INT006079

  • MeSH (NLM) C572941ipragliflozinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 3N2N8OOR7XIPRAGLIFLOZINConfirmed FDA, NLM, Wikidata
  • Wikidata Q17193526ipragliflozinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166685IpragliflozinOne source FDA
  • DrugBank DB11698One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.